agilon health (NYSE:AGL) Price Target Lowered to $2.00 at Stifel Nicolaus

agilon health (NYSE:AGL) had its price target lowered by research analysts at Stifel Nicolaus from $7.00 to $2.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ target price would suggest a potential upside of 6.95% from the company’s previous close.

Several other brokerages have also issued reports on AGL. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. TD Cowen lowered their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday. Finally, Benchmark reaffirmed a “buy” rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, agilon health currently has an average rating of “Hold” and an average price target of $7.03.

agilon health Trading Down 13.4 %

NYSE:AGL traded down $0.29 during trading hours on Tuesday, hitting $1.87. The company had a trading volume of 3,957,468 shares, compared to its average volume of 4,960,215. The company has a market capitalization of $769.47 million, a PE ratio of -1.99 and a beta of 0.60. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a 50-day moving average price of $3.22 and a 200 day moving average price of $4.95. agilon health has a 52 week low of $1.80 and a 52 week high of $13.76.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 46.06% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the company earned ($0.06) earnings per share. On average, equities research analysts predict that agilon health will post -0.32 EPS for the current fiscal year.

Insider Transactions at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after purchasing an additional 371,537 shares during the period. Capital International Investors raised its holdings in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the period. Citigroup Inc. grew its stake in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after buying an additional 174,883 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.